bioMerieux (OTCMKTS:BMXMF – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $131.00, but opened at $120.85. bioMerieux shares last traded at $120.85, with a volume of 123 shares traded.
bioMerieux Price Performance
The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08. The firm’s 50 day simple moving average is $126.52 and its two-hundred day simple moving average is $133.97.
About bioMerieux
bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.
Featured Stories
- Five stocks we like better than bioMerieux
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Punch these codes into your ordinary brokerage account
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Zacks Puts $25.50 target on BSEM!
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
